Compare Heron Therapeutics Inc (HRTX) vs NIO Inc. (NIO) Price & Performance

Heron Therapeutics IncTrade

NIO Inc.Trade

Price performance (Past 24H)

Key statistics

Heron Therapeutics Inc vs NIO Inc. — how do they compare? Heron Therapeutics Inc trades at $0.32 (market cap $63.41M), while NIO Inc. trades at $4.56 (market cap $12.12B). The key difference: NIO Inc. is far larger — about 191.1× Heron Therapeutics Inc's market cap. Which is the better fit depends on your goals.

	HRTX	NIO
Market Cap	$63.41M	$12.12B
Sector	Health	Consumer Cyclical
52-Week High	$1.49	$7.89
52-Week Low	$0.32	$4.44
Enterprise Value	$161.31M	$11.35B

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Heron Therapeutics Inc

Heron Therapeutics (HRTX) trades at $0.49, down 1.64% today, with a bearish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7M but missed earnings expectations with a $0.03 loss per share. Despite negative net income margins, HRTX maintains strong analyst support with 94.7% buy ratings. Recent news highlights patent litigation developments and quarterly earnings underperformance.

HRTX faces significant fundamental challenges with persistent losses and declining revenue projections, though analyst consensus remains overwhelmingly bullish. Investment opportunity exists if the company can achieve profitability and meet growth targets, but risks include ongoing operational losses, competitive pressures, and execution challenges in the biotechnology sector.

NIO Inc.

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

HRTX

Heron Therapeutics misses Q2 earnings and revenue estimates, pauses sales expansion, withdraws full-year outlook.Alex Lavoie · 1 day agoBearish View details →

NIO

Nio shares drop 5% after BlackRock reduces stake despite strong delivery growth.24/7 Wall Street · 22 hours agoBearish Software-defined vehicle market to hit $1.7T by 2035, driven by AI, OTA updates, and centralized computing.Researchandmarkets.Com · 4 days agoBullish View details →

About Heron Therapeutics Inc

Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.

About NIO Inc.

NIO Inc. manufactures and sells automobiles. The Company offers electric vehicles and parts, as well as provides battery charging services. NIO serves customers worldwide.